New Eye Injection Could Cut AMD Treatment to Once a Year

Scientists developed a gene therapy that could reduce painful monthly eye injections for macular degeneration patients down to just once or twice a year.

The breakthrough offers hope to nearly 20 million Americans battling the leading cause of vision loss in older adults.